外来がん化学療法登録レジメン肺癌 非小細胞肺癌 Atezolizumab CBDCA+GEM CBDCA+nab-PTX CBDCA+nab-PTX+Atezolizumab CBDCA+nab-PTX+Pembrolizumab CBDCA+PEM+Atezolizumab CBDCA+PEM+Nivolumab+Ipilimumab CBDCA+PEM+Pembrolizumab CBDCA+PEM±BEV CBDCA+PTX+Atezolizumab+BEV CBDCA+PTX+Nivolumab+Ipilimumab CBDCA+PTX+Pembrolizumab CBDCA+PTX±BEV CBDCA+S-1 CDDP+DTX CDDP+GEM CDDP+GEM+Necitumumab CDDP+PEM+Atezolizumab CDDP+PEM+Nivolumab+Ipilimumab CDDP+PEM+Pembrolizumab CDDP+PEM±BEV CDDP+S-1 CDDP+VNR CPT-11 DTX DTX+RAM Durvalumab Erlotinib+RAM Gefitinib+RAM GEM Low dose CBDCA+RT nab-PTX Nivolumab (240mg) Nivolumab (240mg)+Ipilimumab Nivolumab (360mg)+Ipilimumab Nivolumab (480mg) PEM Pembrolizumab (200mg) Pembrolizumab (400mg) VNR weekly CBDCA+weekly PTX+RT
